cell
control
pathogen
tumor
must
function
site
oxygen
tension
frequent
low
never
high
atmospher
cultur
condit
howev
tcell
function
vivo
gener
analyz
indirectli
extrapol
vitro
studi
nonphysiolog
oxygen
tension
studi
delin
role
physiolog
patholog
oxygen
tension
vitro
reactiv
differenti
tumorspecif
cell
use
cell
mice
observ
gener
ctl
correspond
physioxia
lymph
node
gave
rise
higher
effector
signatur
gener
atmospher
oxygen
fraction
hypoxia
modifi
cytotox
decreas
tension
ctl
tumorinfiltr
lymphocyt
reactiv
dosedepend
decreas
prolifer
induc
secret
immunosuppress
cytokin
upregul
express
overal
data
indic
oxygen
tension
key
regul
tcell
function
fate
suggest
releas
may
unanticip
compon
cellmedi
immun
respons
vivo
microenviron
cell
r
oxygen
r
hypoxia
r
r
tcell
reactiv
addit
support
inform
may
found
onlin
version
articl
publish
websit
refer
ivanov
z
hypoxia
situ
normoxia
stem
cell
paradigm
hypoxia
hypoxiainduc
factor
regul
cell
develop
differenti
function
immunol
re
partial
oxygen
pressur
human
tissu
crucial
paramet
small
molecul
hypoxia
al
hypoxia
import
tumor
biolog
noninvas
measur
imag
valu
measur
manag
cancer
therapi
int
j
radiat
biol
healthi
physiolog
context
oxygen
tension
mammalian
tissu
tightli
regul
still
show
signific
variat
tissu
within
tissu
support
inform
fig
infect
contrast
suffici
oxygen
suppli
ie
normoxia
oxygen
depriv
ie
hypoxia
lead
cellular
respons
involv
correspond
dr
paul
r
walker
email
paulwalk
hcugech
stabil
hif
hypoxiainduc
factor
transcript
factor
compos
induc
ie
togeth
constitut
ie
upon
stabil
hif
transcrib
variou
gene
hifrespons
element
promot
includ
increas
angiogenesi
eg
vegf
glucos
metabol
eg
glucos
transport
interestingli
uniqu
redund
oppos
role
furthermor
describ
stabil
activ
acut
manner
shown
stabl
chronic
manner
howev
although
hif
central
mani
hypoxia
respons
certain
effect
shown
hifindepend
intriguingli
also
involv
immun
cell
activ
atmospher
oxygen
fraction
ato
ie
report
macrophag
cell
hypoxia
essenti
vivo
microenvironment
phenomenon
challeng
studi
recapitul
vitro
explor
hypoxia
one
compar
hypox
normox
condit
howev
publish
studi
consid
ato
normoxia
could
lead
misinterpret
exampl
physiolog
oxygen
fraction
physioxia
found
secondari
lymphoid
organ
close
induc
differenti
lymphocyt
activ
compar
ato
vitro
highlight
necess
use
physioxia
refer
point
studi
hypoxia
impact
vitro
also
analyz
cell
physiolog
gener
physioxia
tissu
vari
greatli
eg
skin
brain
pulmonari
alveoli
support
inform
fig
baselin
physioxia
healthi
tissu
previous
use
assess
lymphocyt
function
also
select
compromis
valu
studi
impact
hypoxia
hif
intens
studi
context
malign
infect
often
posit
correl
pathogenesi
cancer
hypoxia
promot
tumor
cell
stem
migrat
invas
metastasi
resist
radiotherapi
chemotherapi
ctlmediat
kill
viral
infect
hypoxia
increas
viral
replic
gene
express
date
impact
hypoxia
cell
implic
antitumor
antivir
immun
extens
describ
studi
focus
cell
without
consensu
regard
effect
earlier
studi
suggest
posit
correl
hypoxia
viabil
prolifer
recent
studi
show
opposit
hypoxia
also
shown
increas
treg
polar
concern
cytokin
product
conflict
result
secret
overal
despit
certain
contradict
emerg
research
area
knowledg
base
cell
becom
comprehens
impact
hypoxia
oxygen
tension
cell
restrict
interest
studi
howev
mani
issu
regard
reactiv
alreadi
prime
cell
hereaft
consid
ctl
requir
investig
particularli
import
understand
ctl
respons
hypoxia
contrast
certain
th
subset
cell
must
function
oxygendepriv
site
bodi
eg
tumor
bed
site
infect
studi
explor
hypoxia
impact
effector
cell
reactiv
either
physioxia
mani
healthi
tissu
hypoxia
found
inflam
tumor
site
support
inform
fig
gene
express
analysi
reactiv
ctl
underlin
import
use
physioxia
instead
ato
normoxia
refer
mani
gene
describ
modul
hypoxia
alreadi
regul
physioxia
investig
immun
function
oxygen
depriv
reveal
wherea
hypoxia
modifi
ctl
kill
capac
potent
induc
secret
upon
reactiv
dramat
decreas
ctl
expans
use
cell
mice
carri
transgen
tcr
direct
immunodomin
epitop
tumorselfantigen
allow
us
obtain
clonal
popul
cell
model
physiolog
effector
tcell
respons
first
gener
ctl
physioxia
found
ln
compar
ctl
gener
ato
ie
perform
comparison
commonli
use
vitro
cell
cultur
normox
control
studi
hypoxia
impact
analyz
express
panel
gene
describ
either
regul
hypoxia
immunefunct
relat
involv
cell
surviv
support
inform
tabl
rel
physiox
oxygen
fraction
use
ctl
gener
upregul
rna
express
differ
gene
describ
increas
hypoxia
includ
exon
albeit
weakli
express
judg
nanostr
absolut
rna
count
data
shown
vegfa
gelsolin
howev
modul
express
downregul
fig
sever
gene
posit
associ
cell
surviv
expans
upregul
includ
howev
maf
associ
increas
apoptosi
immun
regul
also
upregul
noteworthi
ctl
gener
physioxia
show
higher
effector
profil
evidenc
fasl
upregul
downregul
fig
consist
observ
ctl
gener
normoxia
show
increas
fig
decreas
express
support
inform
fig
due
tcell
clone
use
oti
ctl
polyclon
ctl
gave
result
support
inform
fig
accordingli
ctl
gener
physioxia
increas
kill
capac
compar
ctl
gener
ato
support
inform
fig
next
investig
whether
hypoxia
could
impact
ctl
lytic
capac
independ
oxygen
fraction
use
ctl
gener
hypoxia
cytotox
assay
effect
support
inform
fig
assay
impli
shortterm
hypoxia
exposur
h
also
precondit
ctl
three
day
carri
kill
assay
interestingli
ctl
gener
ato
precondit
hypoxia
show
increas
cytotox
fig
howev
ctl
gener
physioxia
precondit
hypoxia
augment
kill
capac
granzymeb
grb
preferenti
express
ctl
gener
physioxia
compar
gener
ato
support
inform
fig
g
consist
increas
effector
versu
memori
differenti
splenocyt
gener
black
bar
gray
bar
analyz
rna
express
result
repres
mean
rel
gene
express
b
rna
absolut
count
sem
five
independ
experi
n
checkerboard
repres
gene
analyz
gene
modul
p
color
red
blue
c
ctl
splenocyt
gener
fraction
indic
analyz
marker
express
flow
cytometri
c
ctl
stain
gate
live
cell
day
day
day
postprim
dot
plot
show
one
repres
experi
day
line
graph
show
mean
percentag
sem
among
ctl
least
four
independ
experi
n
ctl
gener
precondit
day
result
ctl
assess
capac
kill
tumor
target
cell
puls
ctl
n
ova
peptid
oti
ctl
n
h
oxygen
fraction
use
precondit
result
show
mean
sem
specif
lysi
tumor
cell
least
three
independ
experi
ns
statist
signific
p
p
p
b
threeway
anova
c
student
ttest
observ
howev
observ
differ
ctl
precondit
hypoxia
therefor
hypoxia
might
improv
ctl
kill
capac
ctl
gener
ato
mechan
independ
grb
product
next
investig
impact
oxygen
tension
expans
alreadi
prime
cell
impact
hypoxia
tcell
antitumor
antivir
respons
critic
examin
ctl
reactiv
occur
alreadi
prime
cell
migrat
nonlymphoid
tissu
exert
effector
function
potenti
hypox
microenviron
model
ctl
gener
physioxia
reactiv
either
physioxia
hypoxia
also
compar
result
ctl
gener
reactiv
ato
support
inform
fig
expect
one
day
postrestimul
stabil
regul
neg
oxygen
fraction
support
inform
fig
howev
two
day
postrestimul
level
decreas
low
oxygen
fraction
highli
stabil
ato
thu
splenocyt
reactiv
two
day
indic
oxygen
fraction
e
rna
profil
ctl
reactiv
black
bar
gray
bar
f
rna
profil
ctl
reactiv
black
histogram
gray
histogram
result
repres
mean
rel
gene
express
sem
four
independ
experi
n
checkerboard
repres
gene
analyz
gene
modul
p
color
red
blue
display
common
gene
modul
condit
gene
compos
checkerboard
organ
ident
arbitrari
fashion
ns
statist
signific
p
p
p
ad
student
ttest
e
f
threeway
anova
confirm
previou
result
show
hif
involv
tcr
signal
found
prime
cell
data
shown
hypoxia
dramat
decreas
ctl
expans
reactiv
fig
associ
reduc
cell
divis
viabil
fig
c
trend
toward
apoptosi
fig
similar
expans
obtain
use
oti
cell
also
polyclon
ctl
mice
support
inform
fig
next
determin
impact
hypoxia
gene
express
reactiv
ctl
hypoxia
highli
impact
numer
gene
compar
ato
fig
howev
compar
physioxia
hypoxia
impact
one
fifth
lesser
extent
fig
ctl
reactiv
two
day
hypoxia
show
increas
express
lesser
extent
gene
analyz
modul
hypoxia
independ
oxygen
fraction
use
normoxia
refer
rna
express
kinet
ifng
support
inform
fig
e
indic
strong
upregul
rna
level
two
day
postreactiv
decreas
although
rna
express
stabl
gene
neg
correl
oxygen
fraction
rna
express
concern
rna
support
inform
fig
express
decreas
two
day
postreactiv
stabl
hypoxia
order
know
whether
modul
due
hypoxia
combin
hypoxia
plu
tcr
stimul
analyz
express
panel
gene
ctl
cultur
two
day
without
stimul
support
inform
fig
upregul
show
hypoxiadriven
upregul
molecul
depend
tcr
stimul
interestingli
upregul
compar
ctl
cultur
vs
cultur
confirm
result
key
gene
protein
level
flow
cytometri
observ
increas
hypoxia
reactiv
ctl
oti
mice
compar
physioxia
ato
fig
b
support
inform
fig
although
upregul
hypoxia
compar
ato
effect
hypoxia
level
comparison
made
physioxia
support
inform
fig
explor
unexpect
product
cell
low
oxygen
tension
analyz
intracellular
product
reactiv
ctl
lower
oxygen
tension
increas
fraction
produc
ctl
fig
fraction
also
coexpress
howev
wherea
hypoxia
augment
fraction
compar
ato
significantli
increas
fraction
compar
physioxia
fig
analysi
secret
indic
weak
secret
ato
moder
induct
physioxia
potent
induct
hypoxia
fig
use
cell
oti
mice
yield
result
support
inform
fig
g
thu
data
suggest
typic
ctl
cytokin
follow
reactiv
physioxia
secret
increas
hypoxia
howev
cytokin
secret
primari
activ
cell
even
prime
physioxia
hypoxia
data
shown
next
test
whether
secret
respons
decreas
cell
expans
hypoxia
use
antibodi
ctl
reactiv
restor
expans
hypoxia
fig
thu
hypoxia
impact
cytokin
secret
profil
ctl
least
without
autocrin
consequ
observ
hypoxiarel
increas
express
fig
support
inform
fig
h
note
undetect
ctl
restimul
data
shown
strongli
upregul
reactiv
ctl
hypoxia
vitro
confirm
result
vivo
ex
vivo
use
tumor
model
show
tumorinfiltr
lymphocyt
til
inde
express
vivo
purifi
til
compar
cell
spleen
wherea
spleen
express
til
fig
cell
coexpress
protein
observ
easili
without
vitro
cell
manipul
look
rna
express
higher
til
compar
splenocyt
fig
moreov
also
overexpress
indic
scatter
graph
show
correl
puriti
mrna
support
inform
fig
mrna
express
contamin
nont
cell
tumor
cell
macrophag
order
confirm
oxygen
fraction
major
regul
til
expans
express
reactiv
til
ex
vivo
bead
vari
oxygen
fraction
ie
previous
describ
use
vitro
gener
ctl
expans
viabil
correl
posit
oxygen
level
fig
final
confirm
vitro
data
observ
fig
importantli
neg
correl
oxygen
level
fig
importantli
upregul
molecul
hypoxia
need
combin
tcrligat
plu
hypoxia
fig
e
addit
secret
slightli
decreas
hypoxia
fig
understand
impact
hypoxia
tcell
respons
repres
import
step
predict
vivo
immun
function
notabl
cancer
infect
inde
develop
immunotherapi
base
cell
eg
vaccin
adopt
cell
transfer
effector
cell
function
hypox
environ
central
issu
judg
impact
hypoxia
choos
appropri
physiolog
oxygen
refer
point
previou
work
cell
convincingli
demonstr
physioxia
consid
significantli
impact
tcell
activ
compar
ato
therefor
unsurpris
littl
consensu
effect
hypoxia
low
oxygen
tension
cell
studi
chose
compar
respons
hypoxia
ato
could
consid
hyperoxia
studi
rational
design
allow
comprehens
appreci
hypoxia
impact
comparison
ato
physioxia
observ
ctl
gener
physioxia
predominantli
effector
rather
memori
phenotyp
increas
grb
content
furthermor
transcript
tabl
repres
pvalu
obtain
twotail
student
ttest
calcul
comparison
made
ctl
gener
reactiv
versu
ctl
gener
reactiv
versu
ctl
gener
reactiv
versu
ctl
gener
reactiv
versu
mean
cytokin
secret
e
g
h
sem
three
independ
experi
n
p
f
cell
yield
ctl
reactiv
four
day
presenc
block
antibodi
open
bar
isotyp
control
close
bar
mean
sd
two
independ
experi
n
p
student
ttest
factor
associ
effector
differenti
upregul
transcript
factor
associ
differenti
persist
memori
cell
downregul
consist
effector
versu
memori
profil
ctl
gener
physioxia
lytic
gener
suggest
ctl
gener
ato
eg
adopt
therapi
could
suboptim
consist
previou
report
increas
granzym
express
cytotox
cell
preactiv
physiolog
oxygen
tension
might
also
link
increas
hif
activ
physioxia
hif
describ
increas
ctl
effector
function
result
show
physioxia
found
secondari
lymphoid
organ
facilit
efficaci
tcell
expans
differenti
vitro
analys
ato
poorli
mimic
vivo
condit
particular
interest
eight
import
gene
describ
hypoxiaregul
includ
wide
report
vegfa
gene
regul
even
physiolog
oxygen
valu
chose
physioxia
ie
compar
ato
impact
oxygen
tension
relev
understand
tcell
prime
physioxia
even
cell
rare
enter
hypox
site
tumor
bed
effector
cell
expect
differ
sensit
activ
stimuli
sinc
phenotyp
distinct
possess
uniqu
metabol
pattern
eg
glucos
cystein
requir
effector
tcell
reactiv
frequent
occur
poorli
oxygen
often
hypox
tissu
lower
oxygen
fraction
prime
howev
critic
issu
surviv
expans
function
vivo
relev
condit
seldom
address
agreement
previou
studi
observ
hypoxia
modifi
ctl
kill
capac
shortterm
assay
regardless
oxygen
tension
use
ctl
gener
nevertheless
notic
precondit
three
day
hypoxia
ctl
gener
ato
increas
lytic
capac
importantli
show
ctl
expans
follow
reactiv
strongli
decreas
hypoxia
decreas
viabil
prolifer
hypothes
underli
defect
may
link
disturb
signal
recent
shown
cell
addit
exogen
til
restor
prolifer
hypoxia
support
inform
fig
despit
elev
express
anoth
explan
could
hypoxiainduc
immun
regul
signal
howev
result
reactiv
cell
line
recent
public
show
hypoxiainduc
decreas
cell
expans
sinc
observ
neither
fasl
downregul
character
adenosinergicinduc
immunosuppress
howev
vivo
microenviron
adenosin
level
shown
high
hypoxiainduc
adenosinergicdepend
independ
inhibit
tcell
expans
might
occur
concomitantli
expect
hypoxia
ctl
reactiv
led
strong
modul
numer
gene
gene
upregul
four
gene
downregul
test
compar
hypoxia
ato
howev
compar
physioxia
hypoxia
much
less
potent
modul
express
five
gene
nevertheless
gene
overlap
identifi
modul
follow
switch
cell
atmospher
hypox
condit
among
two
upregul
gene
confirm
overexpress
protein
level
previous
report
hypoxiaregul
particular
interest
whole
panel
gene
analyz
highli
modul
gene
ctl
hypoxia
propos
identifi
hypoxia
impact
rel
physioxia
rather
ato
best
approach
identifi
truli
hypoxia
regul
gene
express
priorit
investig
vivo
signific
hypox
tissu
concern
cytokin
secret
ctl
secret
less
hypoxia
might
consequ
decreas
ctl
expans
hypoxia
howev
despit
consist
rna
express
ctl
til
secret
increas
amount
immunomodulatori
cytokin
restimul
physioxia
hypoxia
hypoxia
potent
induc
observ
effector
cell
prime
cell
hypoxia
lead
secret
data
shown
sinc
observ
neglig
secret
ctl
reactiv
ato
result
suggest
capac
ctl
underestim
convent
vitro
methodolog
like
occur
vivo
mani
tissu
observ
til
limit
number
report
concern
product
cell
awar
context
infect
coronavirusinduc
acut
enceph
chronic
mycobacterium
tuberculosi
infect
respiratori
viral
infect
ctlproduc
suggest
feedback
mechan
dampen
immunopatholog
caus
excess
cytolyt
inflammatori
activ
result
support
function
sinc
hypoxia
featur
infect
tissu
howev
although
mainli
known
immunosuppress
activ
studi
shown
immunostimulatori
effect
observ
stimulatori
inhibitori
effect
ctlexpans
hypoxia
complex
vivo
microenviron
could
act
paracrin
manner
immun
cell
tumor
cell
malign
role
still
matter
debat
promot
tumor
immun
surveil
report
also
correl
poor
prognosi
increas
cancer
recurr
metastasi
critic
determin
futur
studi
whether
produc
tumorspecif
ctl
impact
therapeut
efficaci
studi
shed
light
specif
effect
low
oxygen
tension
hypoxia
function
fate
effector
cell
vitro
model
tissu
oxygen
use
monoclon
cell
ident
sensit
ligand
preclud
potenti
drawback
select
certain
clone
within
polyclon
cell
increas
fit
affin
given
oxygen
tension
nevertheless
major
find
similar
polyclon
ctl
til
data
challeng
use
ato
normoxia
order
determin
vivo
impact
hypoxia
vitro
overal
show
even
hypoxia
disturb
lytic
capac
ctl
could
diminish
antitumor
antivir
respons
vivo
neg
impact
cell
fate
induct
secret
could
act
paracrin
manner
immun
cell
type
tissu
releas
ctl
dampen
inflammatori
respons
hypox
tissu
vivo
may
valuabl
feedback
mechan
limit
immunopatholog
infect
like
blunt
tumor
immunosurveil
immunotherapi
mice
jackson
laboratori
carri
tcr
transgen
specif
human
silv
crossreact
mous
oti
mice
charl
river
carri
tcr
transgen
specif
ovalbumin
tumor
induc
subcutan
inject
cell
anim
use
accord
swiss
feder
law
anim
protect
permiss
number
thymoma
cell
line
atcc
grown
dmem
medium
contain
gl
glucos
sodium
pyruv
glutamax
gibco
supplement
fetal
bovin
serum
penicillin
streptomycin
leukocyt
extract
spleen
lymph
node
oti
mice
cell
prime
nm
nm
ova
respect
polyclon
ctl
gener
cell
neg
select
use
miltenyi
tcell
isol
kit
ii
puriti
prime
plate
coat
cell
cultur
oxygen
dmem
medium
contain
gl
glucos
sodium
pyruv
glutamax
supplement
fetal
bovin
serum
hepe
buffer
arginin
asparagin
penicillin
streptomycin
cell
split
everi
two
day
iuml
human
recombin
result
ctl
use
day
postactiv
tumor
reach
cm
harvest
process
extract
til
briefli
tumor
digest
collagenas
leukocyt
isol
ficol
use
miltenyi
kit
support
inform
fig
b
ctl
label
cfse
invitrogen
track
cell
prolifer
ctl
til
reactiv
plu
bead
dynabead
invitrogen
celltobead
ratio
til
reactiv
perform
presenc
iuml
onefour
day
postreactiv
supernat
collect
cytokin
assess
block
antibodi
clone
biolegend
correspond
isotyp
ad
cultur
experi
viabl
cell
identifi
use
livedead
yellow
marker
invitrogen
support
inform
fig
surfac
marker
express
cell
stain
apc
clone
biolegend
clone
ebiosci
clone
bd
pharmingen
clone
biolegend
clone
ebiosci
clone
biolegend
clone
invitrogen
clone
biolegend
antibodi
appropri
isotyp
control
intracellular
cytokin
stain
ctl
activ
day
plu
bead
incub
overnight
golgiplug
bd
bioscienc
result
cell
stain
follow
intracellular
stain
fixperm
kit
bd
bioscienc
clone
biolegend
clone
biolegend
appropri
isotyp
control
apoptosi
determin
cell
stain
annexinvapc
immunotool
propidium
iodid
pi
bd
bioscienc
pi
annexinv
cell
consid
apoptot
median
fluoresc
intens
medfi
determin
use
gallio
flow
cytomet
beckman
coulter
marker
express
calcul
medfi
markermedfi
control
isotyp
absolut
cell
number
determin
use
cellbead
number
ratio
normal
cell
puls
h
differ
concentr
label
cfse
subsequ
discrimin
result
cell
cocultur
ctl
h
two
assay
perform
either
cocultur
ctl
directli
obtain
day
prime
cocultur
ctl
beforehand
precondit
day
cell
death
quantifi
flow
cytometri
livedead
fixabl
yellow
dead
cell
stain
kit
ctl
kill
calcul
follow
specif
lysi
ctlinduc
cell
death
spontan
cell
death
spontan
cell
death
cell
cultur
place
classic
incub
ato
co
ctl
gener
cell
incub
ruskinn
vivo
workstat
co
cellular
manipul
carri
condit
prevent
reoxygen
cell
hypox
chamber
billupsrothenberg
inc
flush
ga
mixtur
compos
n
co
n
co
use
cultur
ctl
reactiv
respect
cultur
medium
buffer
cell
manipul
preequilibr
overnight
ga
concentr
correspond
subsequ
cultureexperiment
condit
rna
extract
use
qiagen
rnaeasi
kit
dnasetr
accord
manufactur
instruct
equal
amount
rna
ng
use
synthes
cdna
primerscript
rt
takara
bio
inc
assess
forward
ccagagccacatgctcctaga
revers
agctggtcctttgtttgaaagaa
forward
tcccagttccaggactacggt
revers
ggccacgcctgacacct
express
normal
actb
forward
ctaaggccaaccgtgaaaagat
revers
cacagcctggatggctacgt
forward
tccacttggtcgctttgct
revers
cttcttgtccacagctttgatga
gene
realtim
quantit
pcr
sd
ht
instrument
appli
biosystem
use
sybr
green
master
mix
appli
biosystem
follow
paramet
use
min
min
cycl
min
reaction
perform
three
replic
raw
ct
valu
obtain
sd
appli
biosystem
ct
method
use
normal
linear
result
rna
dri
cell
pellet
extract
use
rneasi
kit
qiagen
two
hundr
eighti
nanogram
rna
hybrid
multiplex
nanostr
probe
sampl
process
accord
publish
procedur
probe
analysi
differ
gene
nanostr
technolog
includ
five
normal
gene
support
inform
tabl
background
correct
done
subtract
raw
count
mean
sd
count
obtain
neg
control
valu
fix
posit
control
use
qualiti
assess
check
ratio
highest
lowest
posit
control
averag
among
sampl
count
target
gene
normal
geometr
mean
three
refer
gene
actb
tbp
select
stabl
use
genorm
algorithm
count
rna
speci
analyz
use
hous
excel
macro
express
count
molecul
rnasampl
cytokin
content
tnf
naiv
effector
tcell
cultur
determin
use
mous
kit
cytometr
bead
assay
bd
opteia
set
bd
bioscienc
statist
signific
evalu
use
twotail
student
ttest
comparison
two
group
use
graphpad
softwar
prism
threeway
anova
test
rna
analysi
